Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Septic bursitis (SB) is a common condition accounting for one third of all cases of inflammatory bursitis. It is often related to professional activities. Management is heterogeneous and either ambulatory or hospital-based, with no recommendations available. This article presents recommendations for managing patients with septic bursitis gathered by 18 rheumatologists from the French Society for Rheumatology work group on bone and joint infections, 1 infectious diseases specialist, 2 orthopedic surgeons, 1 general practitioner and 1 emergency physician. This group used a literature review and expert opinions to establish 3 general principles and 11 recommendations for managing olecranon and prepatellar SB. The French Health authority (Haute Autorité de santé [HAS]) methodology was used for these recommendations. Designed for rheumatologists, general practitioners, emergency physicians and orthopedic surgeons, they focus on the use of biological tests and imaging in both outpatient and inpatient management. Antibiotic treatment options (drugs and duration) are proposed for both treatment modalities. Finally, surgical indications, non-drug treatments and prevention are covered by specific recommendations. Copyright © 2023 Société française de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.

Citation

Christelle Darrieutort-Laffite, Guillaume Coiffier, Florence Aïm, Fréderic Banal, Géraldine Bart, Pascal Chazerain, Marion Couderc, Pascal Coquerelle, Emilie Ducourau Barbary, René-Marc Flipo, Maël Faudemer, Sophie Godot, Céline Hoffmann, Thibaut Lecointe, Christian Lormeau, Denis Mulleman, Jean-Maxime Piot, Eric Senneville, Raphaèle Seror, Christine Voquer, Arthur Vrignaud, Pascal Guggenbuhl, Carine Salliot. 2023 French recommendations for diagnosing and managing prepatellar and olecranon septic bursitis. Joint bone spine. 2024 Mar;91(2):105664

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 37995861

View Full Text